Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.8 USD | -0.50% | -15.40% | -50.32% |
Apr. 18 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
Mar. 26 | 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.32% | 3.31B | |
+0.99% | 12.66B | |
-17.03% | 7.04B | |
+2.55% | 5.39B | |
-2.51% | 4.45B | |
+1.73% | 4.32B | |
+6.90% | 2.6B | |
-15.97% | 2.01B | |
-3.40% | 1.67B | |
-15.51% | 1.65B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- Goldman Sachs Downgrades 10x Genomics to Sell From Neutral, Lowers Price Target to $35 From $55